TRV GP III’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

TRV GP III’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,741,636	Closed	-$25.7M	–	6
2020 Q1	$25.7M	Hold	9,741,636	–	–	7%	4
2019 Q4	$11.5M	Hold	9,741,636	–	–	5.08%	4
2019 Q3	$16.8M	Hold	9,741,636	–	–	9.49%	3
2019 Q2	$46.2M	Hold	9,741,636	–	–	19.63%	2
2019 Q1	$62.9M	Hold	9,741,636	–	–	30.82%	2
2018 Q4	$49M	Hold	9,741,636	–	–	41.06%	2
2018 Q3	$83.2M	Hold	9,741,636	–	–	37.15%	2
2018 Q2	$123M	Buy	+9,741,636	New	+$133M	40.88%	2

TRV GP III's NTGN Position: Q2 2020 in Review

TRV GP III sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 9,741,636 shares — an estimated $25.7M sold.

TRV GP III first reported a position in NTGN in Q2 2018 and held it in 8 quarters. The position peaked at $123M in Q2 2018. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

TRV GP III reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
TRV GP III sold 9,741,636 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $25.7M.
TRV GP III first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
TRV GP III's Neon Therapeutics, Inc. Common Stock position peaked at $123M in Q2 2018.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on TRV GP III's 13F filing for Q2 2020, filed 7 Aug 2020.